glp 1 boehringer ADA: Tolerability questions linger for Boehringer's obesity drug Best-In-Class In MASH? Boehringer's Hopes

GHK-Cu reverses follicle miniaturisation by stimulating keratinocyte proliferation and expanding the follicle base (Pickart et al., 2012)

Insulin treatment must be closely monitored with regular glucose measurements (fasting and post-prandial measurements, or via the use of continuous glucose monitoring if available) and adjusted as therapeutic goals are achieved (Garber 2020)

*price with paid upfront first order of 12-week plan

This case raised questions about whether GLP-1 medications might trigger autoimmune responses in susceptible individuals, adding another layer of complexity to an already nuanced picture